Novo Nordisk Implements Global Hiring Freeze Amid Wegovy Pressure
Novo Nordisk, the pharmaceutical major behind the blockbuster obesity drug Wegovy, has imposed a global hiring freeze, halting recruitment for all non-critical positions. The move reflects intensifying pressure from increasing competition and market volatility.
Novo Nordisk Implements Global Hiring Freeze Amid | 21/08/2025 | By Darshana | 180
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy